JWM
REGN icon

Janiczek Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Janiczek Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$241K Buy
229
+8
+4% +$7.75K 0.05% 164
2024
Q1 		$213K Buy
221
+37
+20% +$35.2K 0.05% 172
2023
Q4 		$162K Buy
184
+24
+15% +$19.8K 0.04% 197
2023
Q3 		$132K Buy
160
+39
+32% +$30.7K 0.03% 206
2023
Q2 		$86.9K Buy
121
+1
+0.8% +$771 0.02% 239
2023
Q1 		$99.5K Buy
120
+5
+4% +$3.77K 0.03% 214
2022
Q4 		$82.2K Sell
115
-3
-3% -$2.21K 0.02% 243
2022
Q3 		$86K Buy
118
+17
+17% +$10.7K 0.03% 227
2022
Q2 		$59K Sell
101
-92
-48% -$59.8K 0.02% 282
2022
Q1 		$134K Buy
193
+63
+48% +$39.9K 0.04% 169
2021
Q4 		$82K Buy
130
+11
+9% +$6.76K 0.02% 218
2021
Q3 		$72K Buy
119
+34
+40% +$21.1K 0.03% 222
2021
Q2 		$47K Buy
85
+67
+372% +$33.9K 0.02% 266
2021
Q1 		$9K Sell
18
-25
-58% -$12.2K ﹤0.01% 557
2020
Q4 		$21K Buy
43
+26
+153% +$14K 0.01% 348
2020
Q3 		$10K Buy
+17
New +$10.3K 0.01% 244

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janiczek Wealth Management's REGN Position: Q2 2024 in Review

Janiczek Wealth Management increased its Regeneron Pharmaceuticals (REGN) stake by 3.6% in Q2 2024, buying an estimated $7.75K and bringing the position to 229 shares worth $241K. The position accounts for 0.05% of the portfolio, ranked #164.

Janiczek Wealth Management first reported a position in REGN in Q3 2020 and has held it in 16 quarters since. 1,331 funds tracked by Wall St. Rank hold REGN as of Q2 2024.

  • Janiczek Wealth Management held 229 shares of Regeneron Pharmaceuticals worth $241K as of Q2 2024.
  • Janiczek Wealth Management bought 8 Regeneron Pharmaceuticals shares in Q2 2024, an estimated $7.75K.
  • Regeneron Pharmaceuticals made up 0.05% of Janiczek Wealth Management's portfolio in Q2 2024, its #164 holding.
  • Janiczek Wealth Management first reported a position in Regeneron Pharmaceuticals in Q3 2020 and has held it in 16 quarters since.
  • 1,331 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2024.

Based on Janiczek Wealth Management's 13F filing for Q2 2024, filed 25 Jul 2024.